FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Committee to Consider Iterum Sulopenem NDA

FDA asks its Antimicrobial Drugs Advisory Committee whether an Iterum NDA for sulopenem etzadroxil/probenecid to treat some uncomplicated urinary trac...

latest-news-card-1
Human Drugs

Group Seeks Clarity on Use-Related Risk Analyses

Biosimilars Forum asks FDA for further information and clarification on certain areas of the agencys recent draft guidance entitled Purpose and Conten...

latest-news-card-1
Human Drugs

Drug Nitrosamine Impurity Control Guidance

FDA publishes a revised guidance on controlling nitrosamine impurities in human drugs.

latest-news-card-1
Medical Devices

Baxter Recalls Volara Circuits, Adapter

Baxter recalls (Class 1) certain Volara Single Patient Use Circuits and Blue Ventilator Adapter Assemblies due to reports that the components handset ...

latest-news-card-1
Federal Register

Flagyl Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Pfizers Flagyl (metronidazole) tablets, 250mg and 500mg, were not withdrawn due to safety or effectivenes...

latest-news-card-1
Human Drugs

Comments on ICH RWD Studies Guidance

Two industry associations give line-by-line comments and edits on an International Council for Harmonization draft guidance on the planning, design, a...

latest-news-card-1
Medical Devices

Labs Ask Court to Throw Out FDAs LDT Rule

The American Clinical Laboratory Association and its fellow plaintiffs ask a Texas federal court to grant summary judgment in favor of its suit challe...

latest-news-card-1
Human Drugs

SoloVital Illegally Marketing Hyaluronic Acid: FDA

FDA warns Chula Vista, CA-based SoloVital it is marketing a misbranded and unapproved hyaluronic acid drug product as a dietary supplement.

latest-news-card-1
Human Drugs

California Man Pleads Guilty to Illegal Etizolam Sales

The Department of Justice says Californian Paul Lamberty pleaded guilty in a Massachusetts federal court to conspiracy to defraud the United States an...

latest-news-card-1
Human Drugs

Vanda Sues FDA Over Pending Tradipitant NDA Decision

Vanda Pharmaceuticals sues FDA, seeking an advisory committee meeting to assess the companys pending NDA for tradipitant and its use in treating sympt...